Unexpected severe consequences of Pikfyve deletion by aP2- or Aq-promoter-driven Cre expression for glucose homeostasis and mammary gland development

Physiological Reports

Volumn 4, Issue 11, 2016, Pages

  Ikonomov, Ognian C ^a   Sbrissa, Diego ^a   Delvecchio, Khortnal ^a   A Rillema, James ^a   Shisheva, Assia ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose PIKfyve knockout; glucose homeostasis; pregnancy induced mammary gland development

Indexed keywords

GLUCOSE; PHOSPHATIDYLINOSITOL 3 KINASE; PIKFYVE PROTEIN, MOUSE; PROLACTIN RECEPTOR;

ADIPOSE TISSUE; ANIMAL; CELL DIFFERENTIATION; FEMALE; GENETICS; GLUCOSE INTOLERANCE; GROWTH, DEVELOPMENT AND AGING; HOMEOSTASIS; INSULIN RESISTANCE; KNOCKOUT MOUSE; METABOLISM; MOUSE; PREGNANCY; PROMOTER REGION; SIGNAL TRANSDUCTION; UDDER; UPREGULATION;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; INSULIN RESISTANCE; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; PREGNANCY; PROMOTER REGIONS, GENETIC; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84974851807     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12812     Document Type: Article

References (85)

1. Abdul-Ghani, M. A., and R. A. DeFronzo. 2009. Pathophysiology of prediabetes. Curr. Diab. Rep. 9:193–199.
2. Balla, T. 2013. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol. Rev. 93:1019–1137.
3. Biddinger, S. B., and C. R. Kahn. 2006. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68:123–158.
4. Bridges, D., J. T. Ma, S. Park, K. Inoki, L. S. Weisman, and A. R. Saltiel. 2012. Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1. Mol. Biol. Cell 23:2955–2962.
5. Chakrabarti, P., and K. V. Kandror. 2015. The role of mTOR in lipid homeostasis and diabetes progression. Curr. Opin. Endocrinol. Diabetes Obes. 22:340–346.
6. Chakrabarti, P., T. English, J. Shi, C. M. Smas, and K. V. Kandror. 2010. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes 59:775–781.
7. Chen, C. C., R. B. Boxer, D. B. Stairs, C. P. Portocarrero, R. H. Horton, J. V. Alvarez, et al. 2010. Akt is required for Stat5 activation and mammary differentiation. Breast Cancer Res. 12:R72.
8. Chen, C. C., D. B. Stairs, R. B. Boxer, G. K. Belka, N. D. Horseman, J. V. Alvarez, et al. 2012. Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes Dev. 26:2154–2168.
9. Choi, S. M., D. F. Tucker, D. N. Gross, R. M. Easton, L. M. DiPilato, A. S. Dean, et al. 2010. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol. Cell. Biol. 30:5009–5020.
10. Cui, Y., G. Riedlinger, K. Miyoshi, W. Tang, C. Li, C. X. Deng, et al. 2004. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 24:8037–8047.
11. Deng, Y., and P. E. Scherer. 2010. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann. N. Y. Acad. Sci. 1212:E1–E19.
12. Di Paolo, G., and P. De Camilli. 2006. Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651–657.
13. Eguchi, J., X. Wang, S. Yu, E. E. Kershaw, P. C. Chiu, J. Dushay, et al. 2011. Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 13:249–259.
14. Guilherme, A., J. V. Virbasius, V. Puri, and M. P. Czech. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9:367–377.
15. Haber, E. P., H. M. Ximenes, J. Procopio, C. R. Carvalho, R. Curi, and A. R. Carpinelli. 2003. Pleiotropic effects of fatty acids on pancreatic beta-cells. J. Cell. Physiol. 194:1–12.
16. Hakim, S., M. C. Bertucci, S. E. Conduit, D. L. Vuong, and C. A. Mitchell. 2012. Inositol polyphosphate phosphatases in human disease. Curr. Top. Microbiol. Immunol. 362:247–314.
17. Halberg, N., I. Wernstedt-Asterholm, and P. E. Scherer. 2008. The adipocyte as an endocrine cell. Endocrinol. Metab. Clin. North Am. 37:753–768, x-xi.
18. He, W., Y. Barak, A. Hevener, P. Olson, D. Liao, J. Le, et al. 2003. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. U. S. A. 100:15712–15717.
19. Heffner, C. S., C. Herbert Pratt, R. P. Babiuk, Y. Sharma, S. F. Rockwood, L. R. Donahue, et al. 2012. Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat. Commun. 3:1218.
20. Herman, M. A., and B. B. Kahn. 2006. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 116:1767–1775.
21. Horseman, N. D., W. Zhao, E. Montecino-Rodriguez, M. Tanaka, K. Nakashima, S. J. Engle, et al. 1997. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16:6926–6935.
22. Huang, S., and M. P. Czech. 2007. The GLUT4 glucose transporter. Cell Metab. 5:237–252.
23. Ikonomov, O. C., D. Sbrissa, K. Mlak, and A. Shisheva. 2002. Requirement for PIKfyve enzymatic activity in acute and long-term insulin cellular effects. Endocrinology 143:4742–4754.
24. Ikonomov, O. C., D. Sbrissa, R. Dondapati, and A. Shisheva. 2007. ArPIKfyve-PIKfyve interaction and role in insulin-regulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes. Exp. Cell Res. 313:2404–2416.
25. Ikonomov, O. C., D. Sbrissa, H. Fenner, and A. Shisheva. 2009a. PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis. J. Biol. Chem. 284:35794–35806.
26. Ikonomov, O. C., D. Sbrissa, and A. Shisheva. 2009b. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem. Biophys. Res. Commun. 382:566–570.
27. +/− mice. J. Biol. Chem. 286:13404–13413.
28. Ikonomov, O. C., D. Sbrissa, K. Delvecchio, H. Z. Feng, G. D. Cartee, J. P. Jin, et al. 2013. Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching. Am. J. Physiol. Endocrinol. Metab. 305:E119–E131.
29. Ikonomov, O. C., D. Sbrissa, M. Venkatareddy, E. Tisdale, P. Garg, and A. Shisheva. 2015. Class III PI 3-kinase is the main source of PtdIns3P substrate and membrane recruitment signal for PIKfyve constitutive function in podocyte endomembrane homeostasis. Biochim. Biophys. Acta 1853:1240–1250.
30. Jeffery, E., R. Berry, C. D. Church, S. Yu, B. A. Shook, V. Horsley, et al. 2014. Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte 3:206–211.
31. Jensen, M. D. 2006. Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism. Eur. Heart J. Suppl. 8:B13–B19.
32. Jones, D. R., R. Foulger, W. J. Keune, Y. Bultsma, and N. Divecha. 2013. PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation. FASEB J. 27:1644–1656.
33. Jung, U. J., and M. S. Choi. 2014. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 15:6184–6223.
34. Koumanov, F., V. J. Pereira, P. R. Whitley, and G. D. Holman. 2012. GLUT4 traffic through an ESCRT-III-dependent sorting compartment in adipocytes. PLoS ONE 7:e44141.
35. Kusminski, C. M., S. Shetty, L. Orci, R. H. Unger, and P. E. Scherer. 2009. Diabetes and apoptosis: lipotoxicity. Apoptosis 14:1484–1495.
36. Lamming, D. W., and D. M. Sabatini. 2013. A Central role for mTOR in lipid homeostasis. Cell Metab. 18:465–469.
37. Lee, K. Y., S. J. Russell, S. Ussar, J. Boucher, C. Vernochet, M. A. Mori, et al. 2013. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 62:864–874.
38. Lenk, G. M., and M. H. Meisler. 2014. Mouse models of PI(3,5)P2 deficiency with impaired lysosome function. Methods Enzymol. 534:245–260.
39. Li, S., L. Tiab, X. Jiao, F. L. Munier, L. Zografos, B. E. Frueh, et al. 2005. Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy. Am. J. Hum. Genet. 77:54–63.
40. Li, C., S. A. McClellan, R. Barrett, and L. D. Hazlett. 2014. Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 55:6886–6900.
41. Liao, Y., and M. C. Hung. 2010. Physiological regulation of Akt activity and stability. Am. J. Transl. Res. 2:19–42.
42. Liu, X., G. W. Robinson, K. U. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen. 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:179–186.
43. Martens, K., A. Bottelbergs, and M. Baes. 2010. Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: implications for metabolism research. FEBS Lett. 584:1054–1058.
44. Mayinger, P. 2012. Phosphoinositides and vesicular membrane traffic. Biochim. Biophys. Acta 1821:1104–1113.
45. McGarry, J. D. 2002. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18.
46. Osundiji, M. A., and M. L. Evans. 2011. Hypothalamic glucose sensing and glycaemic disease. Curr. Diabetes Rev. 7:84–98.
47. Pajvani, U. B., M. Hawkins, T. P. Combs, M. W. Rajala, T. Doebber, J. P. Berger, et al. 2004. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279:12152–12162.
48. Palmer, C. A., M. C. Neville, S. M. Anderson, and J. L. McManaman. 2006. Analysis of lactation defects in transgenic mice. J. Mammary Gland Biol. Neoplasia 11:269–282.
49. Parton, L. E., C. P. Ye, R. Coppari, P. J. Enriori, B. Choi, C. Y. Zhang, et al. 2007. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449:228–232.
50. Pendaries, C., H. Tronchere, L. Arbibe, J. Mounier, O. Gozani, L. Cantley, et al. 2006. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J. 25:1024–1034.
51. Ramel, D., F. Lagarrigue, S. Dupuis-Coronas, G. Chicanne, N. Leslie, F. Gaits-Iacovoni, et al. 2009. PtdIns5P protects Akt from dephosphorylation through PP2A inhibition. Biochem. Biophys. Res. Commun. 387:127–131.
52. Rhodes, C. J., M. F. White, J. L. Leahy, and S. E. Kahn. 2013. Direct autocrine action of insulin on beta-cells: does it make physiological sense? Diabetes 62:2157–2163.
53. Rillema, J. A. 1994. Development of the mammary gland and lactation. Trends Endocrinol. Metab. 5:149–154.
54. Rillema, J. A., and M. Schneider-Kuznia. 1980. Observations on the early actions of prolactin on RNA and casein synthesis in mouse mammary gland explants. Horm. Res. 12:218–223.
55. Robinson, G. W., and L. Hennighausen. 2011. MMTV-Cre transgenes can adversely affect lactation: considerations for conditional gene deletion in mammary tissue. Anal. Biochem. 412:92–95.
56. Sarkes, D., and L. E. Rameh. 2010. A novel HPLC-based approach makes possible the spatial characterization of cellular PtdIns5P and other phosphoinositides. Biochem. J. 428:375–384.
57. Sbrissa, D., O. C. Ikonomov, and A. Shisheva. 1999. PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. J. Biol. Chem. 274:21589–21597.
58. Sbrissa, D., O. C. Ikonomov, J. Strakova, R. Dondapati, K. Mlak, R. Deeb, et al. 2004a. A mammalian ortholog of Saccharomyces cerevisiae Vac14 that associates with and up-regulates PIKfyve phosphoinositide 5-kinase activity. Mol. Cell. Biol. 24:10437–10447.
59. Sbrissa, D., O. C. Ikonomov, J. Strakova, and A. Shisheva. 2004b. Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation. Endocrinology 145:4853–4865.
60. Sbrissa, D., O. C. Ikonomov, Z. Fu, T. Ijuin, J. Gruenberg, T. Takenawa, et al. 2007. Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J. Biol. Chem. 282:23878–23891.
61. Schmidt, J. W., B. L. Wehde, K. Sakamoto, A. A. Triplett, S. M. Anderson, P. N. Tsichlis, et al. 2014. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis. Mol. Cell. Biol. 34:1363–1377.
62. Shetty, S., C. M. Kusminski, and P. E. Scherer. 2009. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol. Sci. 30:234–239.
63. Shisheva, A. 2008a. Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3,4,5)P3. Am. J. Physiol. Endocrinol. Metab. 295:E536–E544.
64. Shisheva, A. 2008b. PIKfyve: partners, significance, debates and paradoxes. Cell Biol. Int. 32:591–604.
65. Shisheva, A. 2012. PIKfyve and its lipid products in health and in sickness. Curr. Top. Microbiol. Immunol. 362:127–162.
66. Shisheva, A., and Y. Shechter. 1992. Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes. Biochemistry 31:8059–8063.
67. Shisheva, A., and Y. Shechter. 1993. Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes. J. Biol. Chem. 268:6463–6469.
68. Shisheva, A., T. C. Sudhof, and M. P. Czech. 1994. Cloning, characterization, and expression of a novel GDP dissociation inhibitor isoform from skeletal muscle. Mol. Cell. Biol. 14:3459–3468.
69. Shisheva, A., D. Sbrissa, and O. Ikonomov. 1999. Cloning, characterization, and expression of a novel Zn2 + -binding FYVE finger-containing phosphoinositide kinase in insulin-sensitive cells. Mol. Cell. Biol. 19:623–634.
70. Shisheva, A., D. Sbrissa, and O. Ikonomov. 2015. Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: evidence and speculation (response to: DOI 10.1002/bies.201300012). BioEssays 37:267–277.
71. Soliman, G. A., H. A. Acosta-Jaquez, and D. C. Fingar. 2010. mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes. Lipids 45:1089–1100.
72. Sun, Y., N. Thapa, A. C. Hedman, and R. A. Anderson. 2013. Phosphatidylinositol 4,5-bisphosphate: targeted production and signaling. BioEssays 35:513–522.
73. Takasuga, S., Y. Horie, J. Sasaki, G. H. Sun-Wada, N. Kawamura, R. Iizuka, et al. 2013. Critical roles of type III phosphatidylinositol phosphate kinase in murine embryonic visceral endoderm and adult intestine. Proc. Natl. Acad. Sci. U. S. A. 110:1726–1731.
74. Toker, A., and S. Marmiroli. 2014. Signaling specificity in the Akt pathway in biology and disease. Adv. Biol. Regul. 55:28–38.
75. Ugi, S., T. Imamura, H. Maegawa, K. Egawa, T. Yoshizaki, K. Shi, et al. 2004. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol. Cell. Biol. 24:8778–8789.
76. Urs, S., A. Harrington, L. Liaw, and D. Small. 2006. Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Transgenic Res. 15:647–653.
77. Viaud, J., F. Boal, H. Tronchere, F. Gaits-Iacovoni, and B. Payrastre. 2014. Phosphatidylinositol 5-phosphate: a nuclear stress lipid and a tuner of membranes and cytoskeleton dynamics. BioEssays 36:260–272.
78. Vicinanza, M., V. I. Korolchuk, A. Ashkenazi, C. Puri, F. M. Menzies, J. H. Clarke, et al. 2015. PI(5)P regulates autophagosome biogenesis. Mol. Cell 57:219–234.
79. Wagner, K. U., and H. Rui. 2008. Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. J. Mammary Gland Biol. Neoplasia 13:93–103.
80. Wang, Z. V., Y. Deng, Q. A. Wang, K. Sun, and P. E. Scherer. 2010. Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocrinology 151:2933–2939.
81. Xiang, X., F. Yuan, J. Zhao, Z. Li, X. Wang, Y. Guan, et al. 2013. Deficiency in pulmonary surfactant proteins in mice with fatty acid binding protein 4-Cre-mediated knockout of the tuberous sclerosis complex 1 gene. Exp. Physiol. 98:830–841.
82. Ye, J. 2007. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr. Metab. Immune Disord. Drug Targets 7:65–74.
83. Yu, Y. H., and H. N. Ginsberg. 2005. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ. Res. 96:1042–1052.
84. Yuan, T. L., and L. C. Cantley. 2008. PI3K pathway alterations in cancer: variations on a theme. Oncogene 27:5497–5510.
85. Zhang, J., Y. Wang, Z. Gao, Z. Yun, and J. Ye. 2012. Hypoxia-inducible factor 1 activation from adipose protein 2-cre mediated knockout of von Hippel-Lindau gene leads to embryonic lethality. Clin. Exp. Pharmacol. Physiol. 39:145–150.